You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Colorcon
Mallinckrodt
Harvard Business School
Merck
McKesson
Moodys

Last Updated: December 2, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for Oltipraz

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the drug development status for Oltipraz?

Oltipraz is an investigational drug.

There have been 5 clinical trials for Oltipraz. The most recent clinical trial was a Phase 3 trial, which was initiated on October 1st 2019.

The most common disease conditions in clinical trials are Non-alcoholic Fatty Liver Disease, Liver Diseases, and Fatty Liver. The leading clinical trial sponsors are PharmaKing, CJ HealthCare Corporation, and Northwestern University.

There are three hundred and ninety-one US patents protecting this investigational drug and four international patents.

Recent Clinical Trials for Oltipraz
TitleSponsorPhase
Oltipraz for Liver Fat Reduction in Patients With Non-alcoholic Fatty Liver Disease Except for Liver CirrhosisPharmaKingPhase 3
Efficacy and Safety of Oltipraz for Liver Fat Reduction in Patients With Non-Alcoholic Fatty Liver Disease Except for Liver CirrhosisPharmaKingPhase 3
Efficacy and Safety of Oltipraz in the Patients With Non-alcoholic Fatty Liver DiseasePharmaKingPhase 2

See all Oltipraz clinical trials

Clinical Trial Summary for Oltipraz

Top disease conditions for Oltipraz
Top clinical trial sponsors for Oltipraz

See all Oltipraz clinical trials

US Patents for Oltipraz

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Oltipraz   Start Trial Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases Halozyme, Inc. (San Diego, CA)   Start Trial
Oltipraz   Start Trial Pyrazolopyrimidine compounds GLAXOSMITHKLINE LLC (Wilmington, DE)   Start Trial
Oltipraz   Start Trial Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof vTv Therapeutics LLC (High Point, NC)   Start Trial
Oltipraz   Start Trial Methods for the prevention and the treatment of rapidly progressive glomerulonephritis INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) (Paris, FR) UNIVERSITE PARIS DESCARTES (Paris, FR)   Start Trial
Oltipraz   Start Trial Six-membered C--N-bonded aryl sulphide and aryl sulphoxide derivatives as pesticides BAYER CROPSCIENCE AKTIENGESELLSCHAFT (Monheim am Rhein, DE)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Oltipraz

Drugname Country Document Number Estimated Expiration Related US Patent
Oltipraz Austria AT448323 2023-03-05   Start Trial
Oltipraz Australia AU2004218354 2023-03-05   Start Trial
Oltipraz Australia AU2006216545 2023-03-05   Start Trial
Oltipraz Australia AU2009245838 2023-03-05   Start Trial
Oltipraz Australia AU2013202475 2023-03-05   Start Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Mallinckrodt
Harvard Business School
Merck
McKesson
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.